SMMT
Summit Therapeutics
SMMT
Meridian score19
4 of 5 factors measured. Quality is not measured for this company.
QualityNo data
MomentumMomentum: 3rd percentile
GrowthGrowth: 92nd percentile
ValuationValuation: 2nd percentile
ExpectationsExpectations: 11th percentile
ResearchNot researched
Evidence to review
- Financial data warning: Net income source review
Stage and trend
Stage 4 · DecliningAbove 21d: noAbove 50d: noAbove 200d: no50d over 200d: no
Weeks in stage1 · week open
30-week lineFalling
From 30-week line-4.7%
Price · Oct 27$15.33
From 52w high-47.6%
Relative volume0.7x
1M-1.0%
3M+19.8%
6M-27.9%